12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Moderna Inc. (MRNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Theleme Partners Patrick Degorce | 7,306,861 | $303,819,280 | +2% | 20.36% |
| 2. | 3,427,600 | $142,519,608 | +60% | 0.02% | |
| 3. | 3,413,100 | $141,916,698 | +36% | 0.02% | |
| 4. | 2,620,800 | $108,972,864 | -26% | 0.55% | |
| 5. | 1,960,600 | $81,521,748 | +88% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 52,631 | Director | 420,407 | 2020-02-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $44.68 | 529 | Officer | 20,446 | 2024-12-09 | Filing | |
| $43.30 | 112 | Officer | 19,837 | 2024-12-03 | Filing | |
| $43.30 | 314 | Officer | 1,443,904 | 2024-12-03 | Filing | |
| $42.79 | 1,420 | Officer | 11,066 | 2024-11-29 | Filing | |
| $42.79 | 1,418 | Officer | 19,717 | 2024-11-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 40,323,750 | $1,676,661,525 | 0.02% | |
| 2. | 38,889,571 | $1,617,028,362 | 1.3% | |
| 3. | 25,791,947 | $1,072,429,159 | 0.02% | |
| 4. | 18,664,634 | $776,075,473 | 0.04% | |
| 5. | 17,577,236 | $730,669,796 | 0.02% |
News See All
12 Best S&P 500 Stocks to Invest in According to Analysts
2024 was a memorable year for the broad market index, which posted a gain of 23.31%, building on the 24.2% return in 2023.
Why MRNA Stock Is Retreating
The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative direction, according to Goldman analyst Salveen Richter.
Why Moderna (MRNA) Stock Is Advancing Today
mRNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.
Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers
Jim Cramer's appearance on Squawk on the Street aired on January 17th covered a wide variety of topics.
Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg's appearance on the Joe ...
11 Stocks That Will Go to the Moon According to Reddit
The earnings season is upon us and the investors are excited to see how the market sets the pace for the rest of 2025.
10 S&P 500 Stocks on Jim Cramer's Radar
Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the leading and lagging stocks within the S&P 500.
10 Firms Post Strong Gains Amid Wall Street Bloodbath
Shares of Sibanye Stillwater grew by 4.78 percent on Tuesday, adding $0.16 to close at $3.51 each as investor sentiment was boosted by news citing aides of incoming president Donald Trump that his administration...
Why Vaccine Stocks, Lucid (LCID) Are Rallying
The Louisiana Department of Health noted yesterday that a 65-year-old hospital patient had died due to bird flu.
Billionaire Hedge Funds
